UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

PloS one, 2022-06, Vol.17 (6), p.e0264741-e0264741

2022

Link zum Volltext

Verfügbarkeit prüfen

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Biomedicines, 2021-10, Vol.9 (10), p.1495

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-02, Vol.26 (2), p.205-210

2020

Link zum Volltext

Verfügbarkeit prüfen

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Hepatology communications, 2022-09, Vol.6 (9), p.2488-2495

2022

Link zum Volltext

Verfügbarkeit prüfen

A not so easy genotype—striking regional differences in SOF / RBV treatment responses in HCV GT 2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S125-S128

2013

Link zum Volltext

Verfügbarkeit prüfen

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2021, Vol.64 (5), p.625-634

2021

Link zum Volltext

Verfügbarkeit prüfen

THU-386-YI Renin-angiotensin inhibitor intake is associated with improved survival in patients with chronic hepatitis C viral infection following SVR-data from the german hepatitis C-registry (DHC-R)

Journal of hepatology, 2024-06, Vol.80, p.S820-S820

2024

Link zum Volltext

Verfügbarkeit prüfen

Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?

Addiction (Abingdon, England), 2018-05, Vol.113 (5), p.868-882

2018

Link zum Volltext

Verfügbarkeit prüfen

Prescription of new HCV-drugs - what has to be considered judicially

Zeitschrift fur Gastroenterologie, 2015-01, Vol.53 (1), p.43

Mauss, Stefan

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Clinical infectious diseases, 2013, Vol.57

2013

Link zum Volltext

Verfügbarkeit prüfen

Therapy of HIV-HBV-coinfection

MMW Fortschritte der Medizin, 2009-04, Vol.151 (18), p.49

Mauss, Stefan

2009

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Journal of hepatology, 2022-07, Vol.77, p.S562-S563

2022

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

Journal of hepatology, 2022-07, Vol.77, p.S16

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1110-1110

2014

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1110

2014

Link zum Volltext

Verfügbarkeit prüfen

Reply

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1110-1110

2014

Link zum Volltext

Verfügbarkeit prüfen

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Journal of viral hepatitis, 2021-10, Vol.28 (10), p.1474-1483

2021

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl 2), p.S129-S137

2013

Link zum Volltext

Verfügbarkeit prüfen

Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021

HIV medicine, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Liver international, 2021-05, Vol.41 (5), p.949-955

2021

Link zum Volltext

Verfügbarkeit prüfen

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Liver international, 2020-03, Vol.40 (3), p.539-548

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic hepatitis B

MMW Fortschritte der Medizin, 2008-04, Vol.150 Spec No 1, p.48

Mauss, Stefan

2008

Link zum Volltext

Verfügbarkeit prüfen

Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)

Zeitschrift fur Gastroenterologie, 2023-05, Vol.61 (5), p.489

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionTaylor & Francis:Master (3349 titles)

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(86)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

A not so easy genotype—striking regional differences in SOF / RBV treatment responses in HCV GT 2

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

THU-386-YI Renin-angiotensin inhibitor intake is associated with improved survival in patients with chronic hepatitis C viral infection following SVR-data from the german hepatitis C-registry (DHC-R)

Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?

Prescription of new HCV-drugs - what has to be considered judicially

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Therapy of HIV-HBV-coinfection

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

Reply

Reply

Reply

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Treatment of chronic hepatitis B

Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)

Aktive Filter

Suchergebnisse filtern